… UMEC is a highly effective bronchodilator that leads to improved lung function when
administered as a single bronchodilator on top of FF in subjects with fully reversible, uncontrolled/…

… therapy, dual bronchodilator agents with a combination of LABA and LAMA was an important
therapy … exacerbations (Group D) should be treated with dual bronchodilator agents initially…

… that dual bronchodilator therapy compared with LABA might result in better symptom control,
with the FEV 1 reaching the MCID with the LAMA component of combination therapy driving …

… We strongly believe that the step-up approach from dual bronchodilation to triple therapy …
exacerbation was lower if the contribution of bronchodilators was excluded, and in any case of …

… bronchodilator therapy in reducing … bronchodilator therapy where COPD exacerbation data
were available for 16 randomized control trials (RCTs; 18,224 patients), LAMA/LABA therapy …

… of long-acting bronchodilators. Therapy was well tolerated by all study groups, with no … and
losartan in basic therapy, while taking long-acting bronchodilators, improves the clinical and …

… Despite dual bronchodilation therapy still represents the cornerstone therapy for most
patients with chronic obstructive pulmonary disease (COPD) [1], to date only few randomized …

… management in COPD are long-acting inhaled bronchodilators, either long-acting … acting
bronchodilator monotherapy, and inhaled corticosteroids (ICSs) can be added for triple therapy (…

… This study is a prespecified subgroup analysis of a 52-week, open-label, parallel-group
randomised controlled trial in patients with mild asthma, which compared as-needed salbutamol …

… is dosed BID it is likely that the bronchodilator efficacy of GB would be greater than tiotropium
… The bronchodilator effects of inhaled glycopyrronium have been studied using both once …